Back to results
US 2014/0154774 A1Published application
Npp1 fusion proteins
AssigneeSynageva BioPharma Corp.
InventorsAnthony Quinn, Alex J. Harvey, Zhinan Xia
Life of this patent
Estimating the term…
Abstract
The present invention provides a novel fusion polypeptide containing a catalytic domain of NPP1 fused to a targeting moiety, nucleic acids encoding the fusion polypeptide, a vector containing the nucleic acid integrated thereinto, a host cell transformed with the vector and pharmaceutical compositions comprising the fusion polypeptide.
Claims16
1-38. (canceled)
An isolated polypeptide comprising a targeting moiety and a catalytic domain of NPP1, wherein said catalytic domain of NPP1 comprises the amino acid sequence set forth from P99 to D925 of SEQ ID NO:1.
Dependencies are inferred from the claim text.